Arjun Agarwal - 29 Aug 2024 Form 3 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
SVP, Finance and Treasurer
Signature
/s/ Paul Quinlan, as attorney-in-fact for Arjun Agarwal
Issuer symbol
ORKA
Transactions as of
29 Aug 2024
Transactions value $
$0
Form type
3
Filing time
06 Sep 2024, 17:01:37 UTC
Next filing
24 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ORKA Stock Option (Right to Buy) 29 Aug 2024 Common Stock 129K $5.16 Direct F1
holding ORKA Warrant (Right to Buy) 29 Aug 2024 Common Stock 85.7K $7.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 128,566 shares of the Issuer's common stock, one quarter of which will vest on March 22, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2 This warrant represents a right to purchase 85,711 shares of the Issuer's common stock, one quarter of which will vest on April 3, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney